• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP- Research highlights high risk of multi-organ complications, death after dengue infection

Lance

MPH, CSP & CIT Retired, CHMM Emeritus
https://www.cidrap.umn.edu/dengue/r...an-complications-death-after-dengue-infection

Research highlights high risk of multi-organ complications, death after dengue infection



Mary Van Beusekom, MS


Today at 12:01 p.m.

Dengue
Dengue survivors are at increased risk for post-infection multi-organ complications, all-cause hospitalization, and death, suggests a study by researchers in Singapore.

For the study, published yesterday in Clinical Microbiology and Infection, the investigators used national dengue registries and healthcare claims databases in Singapore on 55,870 adults infected from January 2017 through June 2023 and 3.1 million uninfected controls.

The aim was to estimate the risk of multi-organ complications, all-cause hospitalization, and death from the mosquito-borne viral illness. Follow-up was 31 to 300 days.

"Dengue has one of the highest global burdens of disease amongst all vector-borne diseases," the study authors noted. "Population-based cohort studies on long-term sequelae post-dengue are lacking, given dengue’s disproportionate burden in tropical low-and-middle-income countries (LMICs) with limited access to diagnostic testing and follow-up."

Two-fold risk of death


Most patients had mild infections and didn't require hospitalization. The probability of all-cause hospitalization (adjusted hazard ratio [aHR], 1.22) and death (aHR, 2.08) was elevated in dengue survivors. The cumulative number of new-onset conditions in dengue patients rose over the follow-up period relative to controls.

The odds of multi-system complications were greater in both hospitalized and non-hospitalized dengue patients. Older age-groups (61 years and older), patients with underlying medical conditions, men, and those infected with the DENV-2 and DENV-3 serotypes were also more vulnerable.

Post-infection, the risk of any complication was 19% (aHR, 1.19), with a 46.0% higher risk of cardiovascular complications (aHR, 1.46) and a 29.0% higher risk of neuropsychiatric complications (aHR, 1.29). The excess burden of any incident complication was 2.07 per 100,000 dengue person-days.

230% greater risk of kidney complications


Specific cardiovascular risks among dengue survivors were major acute cardiovascular events (aHR, 1.31), abnormal heart rhythms (aHR, 1.46), and ischemic heart disease (aHR, 1.254). Neuropsychiatric risks included impaired cognition (aHR, 1.66), other neurologic disorders (aHR, 1.32), and stress and/or anxiety (aHR, 1.57), and gastrointestinal risks were gastritis (aHR, 1.48) and non-infectious hepatitis/cirrhosis (aHR, 3.66).

Development of multidisciplinary care strategies to reduce chronic health loss post-dengue infection is crucial.

Dengue patients were at a 37.0% higher risk for autoimmune disorders (aHR, 1.37), a 19% greater risk for endocrine disorders (aHR, 1.19), a 42.0% higher risk for gastrointestinal complications (aHR, 1.42), and a 230.0% higher risk for renal complications (aHR, 2.30).

Autoimmune disorders included higher risks among dengue patients were connective-tissue-disorders (aHR, 2.43). The risk of endocrine disorders (aHR, 1.19) and abnormal cholesterol levels (aHR, 1.19) was also elevated.

"Increased risk of long-term sequelae post-dengue infection across multiple organ systems may reflect the systemic nature of acute dengue infection," the researchers concluded. "Chronic multi-systemic sequelae may increase morbidity arising from dengue infection. Development of multidisciplinary care strategies to reduce chronic health loss post-dengue infection is crucial."
 
Back
Top Bottom